Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02848989 · ClinicalTrials.gov registry record · NA

Qigong For PPSP In Breast Cancer Pain In Breast Cancer Survivors

A NA study, sponsored by Dana-Farber Cancer Institute.

Completed
Registry status
NA
Development phase
21
Enrollment target

NCT02848989 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 21 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02848989, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.

COMPLETED
Registry status
NA
Development phase
21 participants
Enrollment target

Study Summary

Studies have shown that on-going pain following breast surgery is common and may limit the ability to participate in physical activity, cause tiredness, difficulty in daily chores/activities as well as other problems. This study is evaluating whether participating in a 12-week Qigong program (pronounced chee kung), an exercise program that involves gentle movements combined with breathing/relaxation techniques, also known as mind-body exercise, leads to improvement of pain, physical function, and quality of life among breast cancer survivors that have significant pain following surgery.

Interventions

  • OTHER Qigong Mind-Body Exercise

Trial Details

FieldValue
Enrollment Target 21 participants
Start Date 2017-04-04
Est. Completion 2023-02-03
Phase NA

Sponsor

Dana-Farber Cancer Institute

781 total trials

What the Registry Record Tells You About NCT02848989

The ClinicalTrials.gov registry entry for NCT02848989 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Qigong Mind-Body Exercise is the first listed.

NCT02848989 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02848989 about?

NCT02848989 is a clinical study titled "Qigong For PPSP In Breast Cancer Pain In Breast Cancer Survivors". Studies have shown that on-going pain following breast surgery is common and may limit the ability to participate in physical activity, cause tiredness, difficulty in daily chores/activities as well as other problems. This study is evaluating whether participating in a 12-week Qigong program (prono...

What is the current status of trial NCT02848989?

This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2017-04-04. Estimated completion is 2023-02-03.

What interventions are being tested in trial NCT02848989?

The interventions under investigation include: Qigong Mind-Body Exercise (OTHER).

Who is sponsoring clinical trial NCT02848989?

This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.